Comparison between International Gemmological IPO and Sai Life Sciences IPO.
International Gemmological IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Sai Life Sciences IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of International Gemmological IPO is up to ₹4,225.00 Cr whereas the issue size of the Sai Life Sciences IPO is up to ₹3,042.62 Cr. The final issue price of International Gemmological IPO is ₹417.00 per share and of Sai Life Sciences IPO is ₹549.00 per share.
| International Gemmological IPO | Sai Life Sciences IPO | |
|---|---|---|
| Face Value | ₹2 per share | ₹1 per share |
| Issue Price (Lower) | ₹397.00 per share | ₹522.00 per share |
| Issue Price (Upper) | ₹417.00 per share | ₹549.00 per share |
| Issue Price (Final) | ₹417.00 per share | ₹549.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ₹39.00 per share | |
| Market Lot Size | 35 shares | 27 shares |
| Fresh Issue Size | 3,53,76,651 shares | 1,73,04,189 shares |
| Fresh Issue Size (Amount) | up to ₹1,475.13 Cr | up to ₹950.00 Cr |
| OFS Issue Size | 6,59,47,242 shares | 3,81,16,934 shares |
| OFS Issue Size (Amount) | up to ₹2,749.87 Cr | up to ₹2,092.62 Cr |
| Issue Size Total | 10,13,23,893 shares | 5,54,21,123 shares |
| Issue Size Total (Amount) | up to ₹4,225.00 Cr | up to ₹3,042.62 Cr |
International Gemmological IPO opens on Dec 13, 2024, while Sai Life Sciences IPO opens on Dec 11, 2024. The closing date of International Gemmological IPO and Sai Life Sciences IPO is Dec 17, 2024, and Dec 13, 2024, respectively.
| International Gemmological IPO | Sai Life Sciences IPO | |
|---|---|---|
| Anchor Bid Date | Dec 12, 2024 | Dec 10, 2024 |
| Issue Open | Dec 13, 2024 | Dec 11, 2024 |
| Issue Close | Dec 17, 2024 | Dec 13, 2024 |
| Basis Of Allotment (Tentative) | Dec 18, 2024 | Dec 16, 2024 |
| Initiation of Refunds (Tentative) | Dec 19, 2024 | Dec 17, 2024 |
| Credit of Share (Tentative) | Dec 19, 2024 | Dec 17, 2024 |
| Listing date (Tentative) | Dec 20, 2024 | Dec 18, 2024 |
| Anchor Lockin End date 1 | Jan 16, 2025 | Jan 14, 2025 |
| Anchor Lockin End date 2 | Mar 17, 2025 | Mar 15, 2025 |
International Gemmological IPO P/E ratio is 50.98, as compared to Sai Life Sciences IPO P/E ratio of 126.42.
| International Gemmological IPO | Sai Life Sciences IPO | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated)
| Company Financials (Restated Consolidated)
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 100 | 41.82 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 76.55 | 35.24 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 50.98 | 126.42 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹18020.85 Cr. | ₹11418.63 Cr. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 76.58% | 11.79% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 80.96% | 15.96% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹4.34 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 76.58% | 8.13% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the International Gemmological IPO Retail Individual Investors (RII) are offered 1,01,27,098 shares while in Sai Life Sciences IPO retail investors are offered 1,01,27,098 shares. Qualified Institutional Buyers (QIB) are offered 3,03,81,296 shares in International Gemmological IPO and 1,10,84,224 shares in Sai Life Sciences IPO.
| International Gemmological IPO | Sai Life Sciences IPO | |
|---|---|---|
| Anchor Investor Reservation | 4,55,71,942 shares | 1,66,26,336 shares |
| Market Maker Reservation | ||
| QIB | 3,03,81,296 shares | 1,10,84,224 shares |
| NII | 1,51,90,647 shares | 83,13,169 shares |
| RII | 1,01,27,098 shares | 1,93,97,394 shares |
| Employee | 52,910 shares | |
| Others | ||
| Total | 10,13,23,893 shares | 5,54,21,123 shares |
International Gemmological IPO subscribed 35.48x in total, whereas Sai Life Sciences IPO subscribed 10.27x.
| International Gemmological IPO | Sai Life Sciences IPO | |
|---|---|---|
| QIB (times) | 48.11x | 29.78x |
| NII (times) | 26.09x | 4.99x |
| Big NII (times) | 29.78x | 6.10x |
| Small NII (times) | 18.70x | 2.78x |
| RII (times) | 11.77x | 1.39x |
| Employee (times) | 21.79x | |
| Other (times) | ||
| Total (times) | 35.48x | 10.27x |
